Agonist-induced Ca2+ sensitization in smooth muscle: redundancy of Rho guanine nucleotide exchange factors (RhoGEFs) and response kinetics, a caged compound study

J Biol Chem. 2013 Nov 22;288(47):34030-34040. doi: 10.1074/jbc.M113.514596. Epub 2013 Oct 8.

Abstract

Many agonists, acting through G-protein-coupled receptors and Gα subunits of the heterotrimeric G-proteins, induce contraction of smooth muscle through an increase of [Ca(2+)]i as well as activation of the RhoA/RhoA-activated kinase pathway that amplifies the contractile force, a phenomenon known as Ca(2+) sensitization. Gα12/13 subunits are known to activate the regulator of G-protein signaling-like family of guanine nucleotide exchange factors (RhoGEFs), which includes PDZ-RhoGEF (PRG) and leukemia-associated RhoGEF (LARG). However, their contributions to Ca(2+)-sensitized force are not well understood. Using permeabilized blood vessels from PRG(-/-) mice and a new method to silence LARG in organ-cultured blood vessels, we show that both RhoGEFs are activated by the physiologically and pathophysiologically important thromboxane A2 and endothelin-1 receptors. The co-activation is the result of direct and independent activation of both RhoGEFs as well as their co-recruitment due to heterodimerization. The isolated recombinant C-terminal domain of PRG, which is responsible for heterodimerization with LARG, strongly inhibited Ca(2+)-sensitized force. We used photolysis of caged phenylephrine, caged guanosine 5'-O-(thiotriphosphate) (GTPγS) in solution, and caged GTPγS or caged GTP loaded on the RhoA·RhoGDI complex to show that the recruitment and activation of RhoGEFs is the cause of a significant time lag between the initial Ca(2+) transient and phasic force components and the onset of Ca(2+)-sensitized force.

Keywords: Calcium; Guanine Nucleotide Exchange Factor (GEF); Rho; Signal Transduction; Smooth Muscle.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Cell Line
  • Gene Silencing / drug effects
  • Guanine Nucleotide Exchange Factors / agonists*
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / metabolism
  • Guanosine 5'-O-(3-Thiotriphosphate) / analogs & derivatives*
  • Guanosine 5'-O-(3-Thiotriphosphate) / pharmacology
  • Humans
  • Mice
  • Mice, Knockout
  • Organ Culture Techniques
  • Phenylephrine / analogs & derivatives*
  • Phenylephrine / pharmacology
  • Protein Multimerization / drug effects
  • Protein Structure, Tertiary
  • Rabbits
  • Rats
  • Receptor, Endothelin A / genetics
  • Receptor, Endothelin A / metabolism
  • Receptors, Thromboxane A2, Prostaglandin H2 / genetics
  • Receptors, Thromboxane A2, Prostaglandin H2 / metabolism
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Rho Guanine Nucleotide Exchange Factors / agonists*
  • Rho Guanine Nucleotide Exchange Factors / genetics
  • Rho Guanine Nucleotide Exchange Factors / metabolism
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism
  • rho-Specific Guanine Nucleotide Dissociation Inhibitors / genetics
  • rho-Specific Guanine Nucleotide Dissociation Inhibitors / metabolism
  • rhoA GTP-Binding Protein / genetics
  • rhoA GTP-Binding Protein / metabolism

Substances

  • 1-(2-nitro)phenylethyl-P(3)-guanosine 5'-O-(3-thio)triphosphate
  • ARHGEF11 protein, human
  • ARHGEF11 protein, mouse
  • ARHGEF12 protein, human
  • Arhgef12 protein, mouse
  • Arhgef12 protein, rat
  • Guanine Nucleotide Exchange Factors
  • PDZ-RhoGEF, rat
  • Receptor, Endothelin A
  • Receptors, Thromboxane A2, Prostaglandin H2
  • Recombinant Proteins
  • Rho Guanine Nucleotide Exchange Factors
  • rho-Specific Guanine Nucleotide Dissociation Inhibitors
  • RHOA protein, human
  • N-2-nitrobenzylphenylephrine
  • Phenylephrine
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • RhoA protein, mouse
  • rho GTP-Binding Proteins
  • rhoA GTP-Binding Protein
  • Calcium